University of California San Francisco

Medical Oncology, University of California, San Francisco School of Medicine, Helen Diller Family Comprehensive Cancer Center

Dr. Emily K. Bergsland is Professor of Clinical Medicine, UCSF; Associate Director for Education, Helen Diller Family Comprehensive Cancer Center and holds the Ernest Rosenbaum, MD, Endowed Chair in Medical Oncology, UCSF. . This is only the third time NANETS has given an Outstanding Service Award - for the NANETS leader whose volunteer contributions took NANETS to a new level of growth; whose volunteer hours far exceeded our highest expectations; and whose passion and commitment to our NET medical community left a lasting impact.

Emily Bergsland, MD is a medical oncologist at the University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center who specializes in gastrointestinal malignancies. She is a Professor of Medicine, Director of the UCSF Center for Neuroendocrine Tumors, and serves as Associate Director for Education for the UCSF Helen Diller Family Comprehensive Cancer Center. Dr. Bergsland leads a clinical-translational research program focused on neuroendocrine neoplasms of all grades, which includes clinical trials and collaborative studies related to biomarkers, imaging and clinical outcomes. She is past president of the North American Neuroendocrine Tumor Society, a longstanding member of the NCCN Neuroendocrine Tumor Guidelines panel, and past chair of the NET Task Force of the NCI Gastrointestinal Steering Committee. Her contributions to the advancement of the Society are only outpaced by her commitment to neuroendocrine disease.


Vay Liang W. Go, MD

Dr. Go is a Distinguished Professor of Medicine and former Executive Chairman of the Department of Medicine at the David Geffen School of Medicine, University of California, Los Angeles (UCLA). He is also Director of the National Center for Complementary and Alternative Medicine-funded UCLA Center for Excellence in Pancreatic Diseases.

Dr. Go was a founding member of NANETS, and helped to shepherd the first group of NANETS guidelines into publication. He is past president of the American Pancreatic Association and is the founding and current Editor-in-Chief of the journal Pancreas. He has received numerous honors and recognition awards including: Research Achievement Award, American Institute for Cancer Research (2001); Lifetime Achievement Award, American Pancreatic Association (2001); Mayo Foundation Distinguished Alumnus Award (2002); American Gastroenterological Association/Miles & Shirley Fiterman Foundation Hugh R. Butt Award for Distinguished Achievement in Clinical Research in Nutrition (2003); Géza Hetényi Memorial Medal, Hungarian Society of Gastroenterology (2006); and American Gastroenterological Association Foundation’s Mentors Research Scholar Award Honoree (2007).


Josh Mailman

Josh is the President of the NorCal CarciNET Community and Past Chairperson of the Patient Advocacy Advisory Board for SNMMI and served on the NANETS Advisory Committee.

Josh is a patient advocate and former executive board member of the Society for Integrative Oncology (SIO) and was named SIO Patient Advocate of Year in 2010. Josh is a member of the National Cancer Institutes's Task force on Neuroendocrine Tumors. In 2015 Josh was honored with the Warner Advocacy Award as well as SNMMI's Presidential Distinguished Service Award.